ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,048Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 307

$670K Total Retail Price of All Prescriptions

Rank: 8 out of 307

569 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Montana
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 569 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

15% of this provider’s 569 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 9,860 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Montana
LEVOTHYROXINE SODIUM 453 407 1 1
LISINOPRIL 433 382 2 3
HYDROCODONE-ACETAMINOPHEN 431 293 S3 3 4
GABAPENTIN 339 301 4 15
SIMVASTATIN 325 281 5 2
FUROSEMIDE 315 299 6 6
OMEPRAZOLE 302 240 7 5
METFORMIN HCL 256 223 8 8
AMLODIPINE BESYLATE 252 232 9 7
CITALOPRAM HBR 245 199 10 14
METOPROLOL TARTRATE 237 227 11 12
POTASSIUM CHLORIDE 213 189 12 10
WARFARIN SODIUM 196 185 13 11
TAMSULOSIN HCL 184 163 14 21
ZOLPIDEM TARTRATE 177 137 15 19
HYDROCHLOROTHIAZIDE 172 145 16 9
MELOXICAM 157 128 17 29
ATORVASTATIN CALCIUM 145 126 18 18
FLUOXETINE HCL 138 91 19 32
FENTANYL 134 88 S2 20 35
ATENOLOL 124 97 21 17
PREDNISONE 124 103 21 37
LISINOPRIL-HYDROCHLOROTHIAZIDE 123 111 23 23
AZITHROMYCIN 118 94 24 55
DOXAZOSIN MESYLATE 117 101 25 61
METOPROLOL SUCCINATE 114 88 26 13
ALLOPURINOL 110 101 27 27
CARVEDILOL 110 100 27 24
CYMBALTA 106 61 29 30
SERTRALINE HCL 98 88 30 22
LOSARTAN POTASSIUM 97 93 31 16
OXYCODONE-ACETAMINOPHEN 96 63 S2 32 63
ZETIA 91 91 33 119
TRIAMTERENE-HCTZ 88 87 34 42
CRESTOR 81 67 35 39
NEXIUM 79 51 36 38
LANTUS 74 71 37 47
OXYBUTYNIN CHLORIDE 74 68 37 87
OXYCODONE HCL 74 32 S2 37 31
DONEPEZIL HCL 73 68 40 34
NAMENDA 73 73 40 41
CEPHALEXIN 73 64 40 95
GLIMEPIRIDE 73 66 40 60
ADVAIR DISKUS 71 64 44 28
PANTOPRAZOLE SODIUM 69 58 45 49
LOSARTAN-HYDROCHLOROTHIAZIDE 68 62 46 46
SULFAMETHOXAZOLE-TRIMETHOPRIM 67 59 47 84
DIGOXIN 67 67 47 36
TRAMADOL HCL 66 55 49 25
FINASTERIDE 64 64 50 105
ROPINIROLE HCL 62 46 51 74
ALENDRONATE SODIUM 61 61 52 20
KLOR-CON M20 60 59 53 64
ESCITALOPRAM OXALATE 60 30 53 91
CLOPIDOGREL 60 47 53 59
TRAZODONE HCL 60 43 53 33
SPIRONOLACTONE 59 46 57 40
SYMBICORT 59 55 57 161
TRIAMTERENE-HYDROCHLOROTHIAZID 59 36 57 183
OLANZAPINE 58 20 60 70
SPIRIVA 53 49 61 48
LYRICA 52 26 62 82
PLAVIX 51 36 63 104
NIFEDIPINE ER 51 51 63 134
PRAVASTATIN SODIUM 50 33 65 26
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 9, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.